about
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs diseaseFeasibility of improving identification of familial hypercholesterolaemia in general practice: intervention development studyAchieving change in primary care--causes of the evidence to practice gap: systematic reviews of reviews.Leaders, leadership and future primary care clinical researchCollecting genetic information in primary care: evaluating a new family history tool.Imparting carrier status results detected by universal newborn screening for sickle cell and cystic fibrosis in England: a qualitative study of current practice and policy challenges.Informing patients of familial diabetes mellitus risk: How do they respond? A cross-sectional survey.Realising the potential of the family history in risk assessment and primary prevention of coronary heart disease in primary care: ADDFAM study protocol.Using family history information to promote healthy lifestyles and prevent diseases; a discussion of the evidence.What hinders minority ethnic access to cancer genetics services and what may help?Addressing the evidence to practice gap for complex interventions in primary care: a systematic review of reviews protocolBenefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to comPrimary care evidence in clinical guidelines: a mixed methods study of practitioners' views.A review of clinical practice guidelines found that they were often based on evidence of uncertain relevance to primary care patientsAutomated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF)--an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trialDoes the evidence referenced in NICE guidelines reflect a primary care population?Using web-based familial risk information for diabetes prevention: a randomized controlled trial.Perspectives on enhancing physical activity and diet for health promotion among at-risk urban UK South Asian communities: a qualitative studyCardiovascular risk assessment and lipid modification: NICE guideline.Achieving change in primary care--effectiveness of strategies for improving implementation of complex interventions: systematic review of reviews.Timeline: Raising the profile of genetics in primary care.The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessmentCan machine-learning improve cardiovascular risk prediction using routine clinical data?Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screeningEffectiveness of physical activity and dietary interventions in South Asian populations: a systematic reviewOpportunities and challenges for enhancing preconception health in primary care: qualitative study with women from ethnically diverse communitiesScreening for Familial Hypercholesterolemia in Children: What Can We Learn From Adult Screening Programs?Collection and use of cancer family history in primary care.Identification and management of familial hypercholesterolaemia: what does it mean to primary care?Availability and quality of coronary heart disease family history in primary care medical records: implications for cardiovascular risk assessmentThe current state of cancer family history collection tools in primary care: a systematic review.Systematic review: family history in risk assessment for common diseases.Family history in public health practice: a genomic tool for disease prevention and health promotion.Introducing genetic testing for cardiovascular disease in primary care: a qualitative studyVenous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case-control analysisAutomated Software System to Promote Anticoagulation and Reduce Stroke Risk: Cluster-Randomized Controlled Trial.Prioritizing health outcomes in a limited world: writing lipid guidelines.The effects of preconception interventions on improving reproductive health and pregnancy outcomes in primary care: A systematic review.Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.Comparison of coronary heart disease genetic assessment with conventional cardiovascular risk assessment in primary care: reflections on a feasibility study.
P50
Q24187920-0A469135-B737-46AA-843D-985DD36DC034Q24658655-5A47D805-5FB2-454D-9AEE-4BC2BADF0943Q26752856-BC879CE3-A987-462F-8E8D-4391DD260C6BQ28385917-578E7917-3B08-4BC3-A152-CBBEBF428A86Q33220694-18D0471F-D908-48FF-B403-EC057584D869Q33310203-92149D56-E1AA-4E2D-A0E4-EF430B6B6B5DQ33318712-DB7C88A2-FC03-4646-97D7-F3613542CEF1Q33509900-10E655E1-2541-466E-A001-ADDFDF358949Q33577414-66F70A1E-85FC-4632-8A89-5F4147C259B5Q33765202-44C79B59-B03B-4275-BC04-5836930EF4E1Q33795591-6F817CA4-41C5-447A-A662-78D6BD6A44C3Q33960590-CCB9789D-22CF-4872-B471-BC111953F43BQ34452593-1455601C-0903-42A6-8F7D-0415343E678DQ34459480-9C9614CE-4468-4CAC-91D4-6667727F4C1FQ34478966-E1A70BB2-0455-4C61-AE01-686773236340Q34617682-4C20DE07-09DF-4E62-99F0-A840F66ABDB8Q34727624-A960BCB4-6C92-4D28-AA9A-F32FE468B525Q35138266-5E843216-8138-44CB-B59A-8DD4A4D6A362Q35795487-7CC621F5-B46B-4084-BE1C-470F09206678Q35877555-34170559-ACF5-4D1E-82E8-37C95A453048Q35930722-8D262036-3979-4858-BBE4-7944E27F1A60Q35992231-8B170424-5419-41A8-BE83-56E41EA08B76Q36334041-E5DE2A42-E32B-4D8F-94F1-7711BFA5425EQ36338172-D02D9DC5-50C3-4F70-B445-FB43C40EA91DQ36558151-B747285A-25AF-494C-A4CD-7EB174254E20Q37065302-AEA11C89-1764-4D5F-9E19-9AD07AEB25FBQ37069579-A2CB65A7-9CD2-47E5-A573-C9C20B82F2D0Q37154767-56650C21-A4B0-4BA6-BF23-B7B66D827587Q37362738-8AE6C364-A873-4747-8FA2-5D540AD9A6B5Q37458522-D9D3C86D-A140-4278-8C1D-47ACAD9E3E07Q37517079-E4E78D1A-0FF3-42CE-9A07-B062F960E82FQ37626347-8EB46449-A547-44F2-91AF-3B6F4CFEA770Q37673200-696E301F-EDAE-42F8-8609-BDA7984B197EQ37725784-1F973EC6-B7AC-4ADE-92F8-3CC578664B82Q37728480-EA0EF16E-46E3-460F-8BF5-3B4B1ABBED1AQ38381828-720F1231-F9B6-4779-9F62-610738361956Q38426998-336F31D4-C703-498C-949F-4D94515B2346Q38648696-D2E95A48-C8F1-45BB-B417-56FEFC038EE8Q39009815-4B62246A-304B-4C74-AA60-B1588D1859E7Q39026617-FE389086-3A52-4065-9813-A03B0B7F93C2
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Nadeem Qureshi
@ast
Nadeem Qureshi
@en
Nadeem Qureshi
@es
Nadeem Qureshi
@sl
type
label
Nadeem Qureshi
@ast
Nadeem Qureshi
@en
Nadeem Qureshi
@es
Nadeem Qureshi
@sl
altLabel
Qureshi N
@en
prefLabel
Nadeem Qureshi
@ast
Nadeem Qureshi
@en
Nadeem Qureshi
@es
Nadeem Qureshi
@sl
P214
P244
P106
P21
P214
P244
n2008181345
P31
P496
0000-0003-4909-0644
P734
P7859
lccn-n2008181345